S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Tourmaline Bio, Inc.

TRML Healthcare
$47.98 $0 (0.00%)
Market Cap: $1.24 B
Gurus Holding
0
Popularity Rank
N/A
% of Shares Held
0.00%
Net Activity (Q4 2025)
-$5.7 M

Guru Ownership Trend

Guru Analysis for Tourmaline Bio, Inc. (TRML)

Based on the latest data, no Super Investors currently hold positions in Tourmaline Bio, Inc. (TRML).

Key Holders

Top 5 by Value

No key holders found by value

Top 5 by Conviction

No key holders found by conviction

Recent Activity Breakdown (Q4 2025)

+$0
Total Buy Value
New Buys 0
Additions 0
-$5.7 M
Total Sell Value
Reductions 0
Sold Out 3

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
0

FAQs for Tourmaline Bio, Inc. (TRML)

Based on the most recent 13F filings tracked by 13Radar, no leading investors currently report a position in Tourmaline Bio, Inc..

During the most recent reporting period, 0 managers trimmed their positions, while 3 fully exited TRML. The total reported sell value was $5.7 M.

No tracked managers opened new positions or increased their holdings in TRML during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date

No data available

Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form